Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
AMOXIL vs AMOXICILLIN PEDIATRIC
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and activating autolytic enzymes, leading to bacterial lysis.
Amoxicillin is a semisynthetic penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). It blocks the transpeptidation step in peptidoglycan cross-linking, leading to cell lysis and death.
Upper respiratory tract infections (e.g., otitis media, sinusitis, pharyngitis/tonsillitis) due to susceptible streptococci, pneumococci, and H. influenzae,Lower respiratory tract infections (e.g., pneumonia, bronchitis) due to susceptible streptococci, pneumococci, and H. influenzae,Genitourinary tract infections (e.g., uncomplicated gonorrhea, cystitis) due to susceptible E. coli, P. mirabilis, and enterococci,Skin and skin structure infections due to susceptible streptococci, staphylococci, and E. coli,Helicobacter pylori eradication (as part of combination therapy),Lyme disease (early localized or early disseminated),Prophylaxis of infective endocarditis (dental procedures) in patients with certain cardiac conditions
Treatment of infections caused by susceptible strains of microorganisms in conditions such as otitis media, sinusitis, pharyngitis, tonsillitis, pneumonia, bronchitis, urinary tract infections, skin and skin structure infections, and gonorrhea,Prophylaxis of infective endocarditis in patients undergoing dental or upper respiratory tract procedures (off-label but per ADA/AHA guidelines),Eradication of Helicobacter pylori (as part of combination therapy)
250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 500 mg every 8 hours or 875 mg every 12 hours.
250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours for adults.
Terminal half-life: 1-1.5 hours (normal renal function); prolonged to 7-20 hours in anuria; neonates: 3-4 hours.
Terminal elimination half-life: 1-1.5 hours in children with normal renal function; prolonged to 7-21 hours in anuria.
Amoxicillin is primarily metabolized through hydrolysis of the beta-lactam ring to inactive penicilloic acid, accounting for 60-70% of the dose; about 10% is metabolized via hepatic pathways to amoxicilloic acid; renal excretion as unchanged drug is 60-80% via tubular secretion and glomerular filtration.
Amoxicillin is primarily metabolized by hydrolysis to penicilloic acid, which is then excreted renally. It does not undergo extensive hepatic metabolism; renal clearance involves tubular secretion and glomerular filtration.
Renal: 60-80% unchanged via tubular secretion and glomerular filtration; Biliary/fecal: minor, <5% excreted in bile; dose adjustment in Cr Cl <30 m L/min.
Renal: 60-80% unchanged via glomerular filtration and tubular secretion; biliary: minor (<10%); fecal: <5%.
17-20%, primarily to albumin.
17-20% bound to serum proteins, primarily albumin.
0.3-0.4 L/kg; indicates distribution into total body water.
0.3-0.5 L/kg; reflects distribution into extracellular fluid and well-perfused tissues; crosses placenta and distributes into pleural, synovial, and peritoneal fluids.
Oral: 75-90% (variable with food, decreased absorption); IM: near 100%.
Oral: 75-90% (absorption is rapid but incomplete; food does not significantly affect absorption).
GFR 10-30 m L/min: 250-500 mg every 12 hours; GFR <10 m L/min: 250-500 mg every 24 hours; hemodialysis: 250-500 mg every 24 hours with an additional dose after dialysis.
Cr Cl 10-30 m L/min: administer every 12 hours. Cr Cl <10 m L/min: administer every 24 hours. Hemodialysis: administer dose after dialysis.
No dose adjustment required for mild to moderate hepatic impairment (Child-Pugh class A or B); caution in severe hepatic impairment (Child-Pugh class C) due to limited data.
No specific dose adjustment required for Child-Pugh A or B. Child-Pugh C: consider dose reduction based on clinical response.
Neonates ≤28 days: 25-30 mg/kg/day divided every 12 hours; Infants and children >28 days: 20-40 mg/kg/day divided every 8 hours; for otitis media: 50-90 mg/kg/day divided every 8-12 hours.
Neonates <4 weeks: 30 mg/kg/day divided every 12 hours. Infants and children >4 weeks: 20-50 mg/kg/day divided every 8 hours (mild-moderate infection) up to 80-100 mg/kg/day divided every 6-8 hours (severe infection).
No specific dose adjustment based solely on age; monitor renal function and adjust dose based on creatinine clearance (Cr Cl) as per renal adjustment guidelines; maintain adequate hydration.
No specific dose adjustment based solely on age; assess renal function and adjust accordingly due to age-related decline in GFR.
None
No FDA black box warning.
Serious hypersensitivity reactions (anaphylaxis) can occur; contraindicated in patients with penicillin allergy,Clostridium difficile-associated diarrhea (CDAD) may occur, ranging from mild diarrhea to fatal colitis,Prolonged use may result in superinfection with resistant organisms,Hepatic dysfunction and cholestatic jaundice (rare),Skin rashes, including morbilliform rash (common in patients with mononucleosis),Decreased efficacy when used with bacteriostatic agents (e.g., tetracyclines, chloramphenicol),Use with caution in patients with renal impairment (Cr Cl <30 m L/min) due to increased risk of seizures with high doses
Serious hypersensitivity reactions (anaphylaxis) may occur; discontinue therapy if allergic reaction occurs. Clostridium difficile-associated diarrhea (CDAD) can occur. Adjust dose in renal impairment. Use caution in patients with mononucleosis due to high incidence of morbilliform rash. Prolonged use may result in superinfection.
Known hypersensitivity to amoxicillin, penicillins, or any component of the formulation,Mononucleosis (high incidence of morbilliform rash)
Hypersensitivity to amoxicillin or any penicillin derivative; history of anaphylactic reaction to beta-lactams.
No significant food interactions; absorption is not altered by food. Avoid excessive alcohol as it may increase risk of GI side effects and hepatotoxicity (rare).
Amoxicillin absorption is not significantly affected by food; may be taken with or without meals. However, to minimize gastrointestinal upset, administer with a small amount of food if needed. Avoid acidic beverages (e.g., fruit juices) within 1 hour of dosing as they may degrade the antibiotic.
Penicillins, including amoxicillin, are generally considered low risk in pregnancy. Animal studies have not shown teratogenic effects. In humans, data from large cohort studies and meta-analyses do not indicate an increased risk of major congenital malformations, preterm birth, or low birth weight. Use is acceptable if clinically indicated across all trimesters.
Amoxicillin is classified as FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Human data from pregnant women indicate no increased risk of major birth defects across all trimesters. Caution in first trimester due to limited data, but generally considered safe.
Amoxicillin is excreted into breast milk in small amounts, with an M/P ratio of approximately 0.02-0.05. The estimated dose to the infant is less than 1% of the maternal weight-adjusted dose. It is generally considered compatible with breastfeeding. However, potential risks include infant sensitization, diarrhea, and rash. Monitor for these effects.
Amoxicillin is excreted into breast milk in low concentrations (M/P ratio approximately 0.01-0.02). Considered compatible with breastfeeding; minimal risk of infant effects such as diarrhea or allergic sensitization. Monitor infant for potential gastrointestinal disturbances.
Physiologic changes in pregnancy (e.g., increased renal blood flow, GFR, and volume of distribution) may reduce serum concentrations of amoxicillin. While standard dosing may be effective, some experts recommend using the higher end of the dosing range or more frequent dosing for severe infections. However, no specific dose adjustment is routinely required; clinical response should guide therapy.
Physiologic changes in pregnancy (increased renal blood flow, glomerular filtration rate, and volume of distribution) may lower serum concentrations. Standard dosing is generally adequate, but severe infections may require dose adjustment. No specific dose reduction recommended; monitor clinical response.
Amoxicillin is a first-line agent for acute otitis media, streptococcal pharyngitis, and uncomplicated community-acquired pneumonia. It has a time-dependent killing mechanism; optimal efficacy requires maintaining serum concentrations above the MIC for >40% of the dosing interval. Dose adjustment is necessary for creatinine clearance <30 m L/min. It is compatible with clavulanate for beta-lactamase coverage. Rash during therapy may indicate non-allergic ampicillin rash (especially with viral infections) or true hypersensitivity; assess carefully.
Amoxicillin pediatric suspension is dosed based on body weight; typical dose is 20-40 mg/kg/day in divided doses every 8 hours. For high-dose therapy (e.g., resistant pneumococcus), 80-90 mg/kg/day in two divided doses. Shake suspension well before each dose. Use within 14 days after reconstitution; discard unused portion. Not for patients with severe renal impairment (Cr Cl <30 m L/min) without dose adjustment. Monitor for rash, diarrhea, and hypersensitivity reactions.
Take exactly as prescribed; complete the full course even if you feel better.,May be taken with or without food; avoid large meals if GI upset occurs.,Report any rash, especially if accompanied by hives or difficulty breathing.,Do not use leftover antibiotics; discard after completing course.,Use additional contraception if on oral contraceptives (may reduce efficacy).,For suspension: shake well, measure dose with provided device, refrigerate and discard after 14 days.
Take this medication exactly as prescribed; complete the full course even if your child feels better.,Shake the bottle well before each dose; measure the dose with the provided dosing device.,Refrigerate the suspension after mixing; do not freeze. Discard any unused portion after 14 days.,Do not give this medication if your child is allergic to penicillins or cephalosporins.,Common side effects include diarrhea, nausea, and rash. Contact your doctor if severe diarrhea or signs of allergic reaction occur.,This medication may reduce the effectiveness of oral contraceptives; use additional birth control if applicable.,Inform your doctor if your child has kidney disease, phenylketonuria (some suspensions contain phenylalanine), or is pregnant/breastfeeding.
No interactions on record
"Amoxicillin may reduce the metabolism of Indinavir via inhibition of CYP3A4, leading to increased plasma concentrations of Indinavir. This can elevate the risk of Indinavir-related toxicities such as nephrolithiasis, hepatotoxicity, and gastrointestinal intolerance. Patients may experience exacerbated adverse effects without a corresponding increase in antiviral efficacy."
"Amoxicillin may inhibit the CYP3A4-mediated metabolism of nicardipine, a calcium channel blocker, leading to increased plasma concentrations of nicardipine. This can potentiate vasodilation and negative chronotropic effects, resulting in an increased risk of hypotension, bradycardia, and peripheral edema. Patients, especially those with pre-existing cardiovascular conditions, should be monitored for enhanced antihypertensive effects and adverse reactions when these drugs are coadministered."
"Amoxicillin may inhibit the metabolism of bortezomib through competitive inhibition of cytochrome P450 enzymes, particularly CYP3A4 and CYP2C19, potentially leading to increased bortezomib exposure. This interaction could result in enhanced toxicity of bortezomib, including peripheral neuropathy, myelosuppression, and gastrointestinal adverse effects. Clinicians should monitor for signs of bortezomib toxicity when amoxicillin is coadministered, especially in patients with pre-existing hepatic impairment or other risk factors."
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about AMOXIL vs AMOXICILLIN PEDIATRIC, answered by our medical review team.
AMOXIL is a Penicillin Antibiotic that works by Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and activating autolytic enzymes, leading to bacterial lysis.. AMOXICILLIN PEDIATRIC is a Penicillin Antibiotic that works by Amoxicillin is a semisynthetic penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). It blocks the transpeptidation step in peptidoglycan cross-linking, leading to cell lysis and death.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between AMOXIL and AMOXICILLIN PEDIATRIC depend on the specific clinical indication. These are both Penicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of AMOXIL is: 250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 500 mg every 8 hours or 875 mg every 12 hours.. The standard adult dose of AMOXICILLIN PEDIATRIC is: 250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours for adults.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between AMOXIL and AMOXICILLIN PEDIATRIC in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. AMOXIL is classified as Category C. Penicillins, including amoxicillin, are generally considered low risk in pregnancy. Animal studies have not shown teratogenic effects. In humans, data from large cohort studies and. AMOXICILLIN PEDIATRIC is classified as Category A/B. Amoxicillin is classified as FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Human data from pregnant women indicate no increased risk of major birth def. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.